Clinical Trials Browser

OTHER × daratumumab × CNS × Clear all

NCT04922723 2026-04-28

PRIDE

Phase 1/2 Active not recruiting

Glioblastoma

NCT07026604 2025-06-18

CCM-DS01

Phase EARLY_PHASE1 Not yet recruiting

Hemangioma, Cavernous, Central Nervous System